Brief: GIC Private Ltd's Long Position In Ordinary Shares Of Alphamab Oncology Falls To 4.96% - Filing
Feb 9 (Reuters) - Hong Kong stock exchange filing:
* GIC PRIVATE LIMITED'S LONG POSITION IN ORDINARY SHARES OF
ALPHAMAB ONCOLOGY 9966.HK REDUCED TO 4.96% ON FEB 3 FROM 5.23%
- HKEX FILING
Source text
Further company coverage: 9966.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)